Vnitr Lek 2005, 51(2):148-152

Heparinem indukovaná trombocytopenie - editorial

J. Novotný
Transfuzní oddělení a krevní banka FN Brno, pracoviště Bohunice, přednosta prim. MUDr. Eva Slavíčková

Received: January 16, 2004; Published: February 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Novotný J. Heparinem indukovaná trombocytopenie - editorial. Vnitr Lek. 2005;51(2):148-152.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ahmad S, Jeske WP, Walenga JM et al. Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies. Clin Appl Thrombos Hemost 1999; 5(4): 259-266. Go to original source... Go to PubMed...
    2. Albeiro L, Kimmerle S, Baumann A et al. Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia. Am J Med 2003; 114(7): 528-536. Go to original source... Go to PubMed...
    3. Amiral J. Antigens involved in heparin-induced thrombocytopenia. Semin Hematol 1999; 36: 7-11.
    4. Amiral J, Peynaud-Debayle E, Wolf M et al. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patents treated with unfractionated or low-molecular-weight heparin. Am J Hematol 1996; 52: 90-95. Go to original source... Go to PubMed...
    5. Amiral J, Wolf M, Fischer AM et al. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 komplexes in patients with heparin-induced thrombocytopenia. Brit J Haematol 1996; 92: 954-959. Go to original source... Go to PubMed...
    6. Balestra B, Quadri P, Demarmels Biasiutti F et al. Low molecular weight heparin-induced thrombocytopenia and skin necrosis distant from injection sites. Eur J Haematol 1994; 53: 61-63. Go to original source... Go to PubMed...
    7. Bauer TL, Arepally G, Konkle BA et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997; 95: 1242-1246. Go to original source... Go to PubMed...
    8. Becker RC. Hirudin-based anticoagulant strategies for patients with suspected heparin-induced thrombocytopenia undergoing percutaneous coronary interventions and bypass grafting. J Thrombos Thrombolys 2000; 10(Suppl 1): S59-S68. Go to original source... Go to PubMed...
    9. Burgess JK, Lindeman R, Chesterman CN et al. Single amino acid mutation of Fcgamma receptor is associated with the development of heparin-induced thrombocytopenia. Brit J Haematol 1995; 91: 761-766. Go to original source... Go to PubMed...
    10. Carroza P, Gabutti L, Gilliet F et al. Heparin-induced systemic inflammatory response syndrome with progressive skin necrosis in haemodialysis. Nephrol Dial Transplant 1997; 12: 2424-2427. Go to original source... Go to PubMed...
    11. Dager WE, White RH. Pharmacotherapy of heparin-induced thrombocytopenia. Expert Opin Pharmacother 2003; 4(6): 19-40. Go to original source... Go to PubMed...
    12. Fabris F, Ahmad S, Cella G et al. Pathophysiology of heparin-induced thrombocytopenia - clinical and diagnostic implications - a review. Arch Pathol Lab Med 2000; 124: 1657-1666. Go to original source...
    13. Folwaczny EK, Stürmer KM. Atypische heparininduzierte Thrombocytopenie (HIT) - "Heparinallergie" mit Thrombocytose. Chirurg 1999; 70: 588-594. Go to original source... Go to PubMed...
    14. Girolami B, Prandoni P, Stefani PM et al. The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood 2003; 101: 2955-2959. Go to original source... Go to PubMed...
    15. Greinacher A. Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost 1995; 21(1): 106-116. Go to original source... Go to PubMed...
    16. Jeske WP, Walenga JM, Szatkowski E et al. Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets. Thrombos Res 1997; 88: 271-281. Go to original source... Go to PubMed...
    17. Kelton JG, Warkentin TE. Diagnosis of heparin-induced thrombocytopenia: still a journey, not yet a destination. Am J Clin Pathol 1995; 104(6): 611-613. Go to original source... Go to PubMed...
    18. Kikta MJ, Keller MP, Humphrey PW et al. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome? Surgery 1993; 114: 705-710. Go to PubMed...
    19. Laster JL, Nicholas K, Silver D. Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies. Arch Intern Med 1989; 149: 2285-2287. Go to original source...
    20. Lindhoff-Last, E, Bauersachs, R. Heparin induced thrombocytopoenia: alternative anticoagulation in pregnancy and lactation. Semin Thromb Hemost 28, 2002, 5: 439 - 446 Go to original source... Go to PubMed...
    21. Lindhoff-Last E, Wenning B, Stein M et al. Risk Factors and Long-term Follow-up of Patients with the Immune Type of Heparin-Induced Thrombocytopenia. Clin Appl Thrombos Hemost 2002; 8(4): 347-352. Go to original source... Go to PubMed...
    22. Meyer O, Salama A, Pittet N et al. Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4). Lancet 1999; 354: 1525-1526. Go to original source... Go to PubMed...
    23. Murphy KD, McCrohan G, DeMarta DA et al. The heparin-induced thrombocytopenia and thrombosis syndrome: treatment with intraarterial urokinase and systemic platelet aggregation inhibitors. Cardiovasc Intervent Radiol 1996; 19: 123-127. Go to original source... Go to PubMed...
    24. Novotný J, Konvičková L. Heparinem indukovaná trombocytopenie - přehledný referát. Vnitř Lék 1998; 44(5): 282-287. Go to PubMed...
    25. O'Shea SI, Ortel TL, Kovalik EC. Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia. Semin Dialys 2003; 16(1): 61-67. Go to original source... Go to PubMed...
    26. Rusconi C, Oneglia C, Sabatini T. Failure of low dosage thrombolytic therapy with streptokinase to treat heparin-induced thrombocytopenia-thrombotic syndrome. Int J Cardiol 1997; 62: 87-89. Go to original source... Go to PubMed...
    27. Stewart MW, Etches WS, Boshkov K et al. Heparin-induced thrombocytopenia: an improved method of detection based on lumi-aggregometry. Brit J Haematol 1995; 91: 173-177. Go to original source... Go to PubMed...
    28. Tomer A, Masalunga C, Abshire TC. Determination of heparin-induced thrombocytopenia: A rapid flow cytometric assay for direct demonstration of antibody-mediated platelet activation. Am J Hematol 1999; 61: 53-61. Go to original source... Go to PubMed...
    29. Verma AK, Levine M, Shalansky SJ et al. Frequency of heparin-induced thrombocytopenia in critical care patients. Pharmacotherapy 2003; 23(6): 745-753. Go to original source... Go to PubMed...
    30. Visentin GP, Malik MK, Cyganiak KA et al. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: platetet factor 4 complexes. J Lab Clin Med 1996; 128: 376-383. Go to original source... Go to PubMed...
    31. Walenga JM, Jeske WP, Wood JJ et al. Laboratory tests for heparin-induced thrombocytopenia: a multicenter study. Semin Hematol 1999; 36(Suppl 1): 22-28.
    32. Walls JT, Curtis JJ, Silver D et al. Heparin-induced thrombocytopenia in patients who undergo open heart surgery. Surgery 1990; 108(4): 686-693. Go to PubMed...
    33. Warkentin TE, Elavathil LJ, Hayward CPM et al. The pathogenesis of venous limb ganrene associated with heparin-induced thrombocytopenia. Ann Intern Med 1997; 127(9): 804-812. Go to original source... Go to PubMed...
    34. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344(17): 1286-1292. Go to original source... Go to PubMed...
    35. Warkentin TE, Sheppard JAI, Horsewood P et al. Impact of the patient population on the risk for heparin induced thrombocytopenia. Blood 2000; 96: 1703-1708. Go to original source...
    36. Warkentin TE. Current agents for the treatment of patients with heparin-induced thrombocytopenia. Curr Opin Pulmon Med 2002; 8(5):405-412. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.